Haemochromatosis gene mutations in idiopathic dilated cardiomyopathy

被引:26
|
作者
Mahon, NG
Coonar, AS
Jeffery, S
Coccolo, F
Akiyu, J
Zal, B
Houlston, R
Levin, GE
Baboonian, C
McKenna, WJ
机构
[1] St George Hosp, Sch Med, Dept Cardiol, London SW17 0RE, England
[2] St George Hosp, Sch Med, Dept Med Genet, London SW17 0RE, England
[3] St George Hosp, Sch Med, Dept Clin Biochem, London SW17 0RE, England
[4] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England
关键词
dilated cardiomyopathy; genetics; haemochromatosis;
D O I
10.1136/heart.84.5.541
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Two common mutations of the haemochromatosis associated gene (HFE) (cys282tyr (C282Y) and his63asp (H63D)) have been implicated in haemochromatosis and as modulators in cardiovascular disease. Objective-To investigate the role of these mutations in the pathogenesis of idiopathic dilated cardiomyopathy. Design and setting-Case-control and prospective cohort study of patients attending a cardiomyopathy unit in a tertiary referral cardiac centre. Methods-207 unrelated white patients with dilated cardiomyopathy, followed up for 259 patient years, and 200 controls were tested for HFE C282Y and H63D mutations by polymerase chain reaction and restriction digestion. Results-31/207 patients (15%) v 24/200 controls (12%) carried C282Y (adjusted odds ratio (OR) 1.2 (95% confidence interval 0.7 to 2.2)), 74/207 (36%) v 53/200 (27%) carried H63D (OR 1.6 (1.1 to 2.5)), and 10/207 (4.8%) v 4/200 (2%) were compound heterozygotes (OR 2.6 (0.8 to 8.5)). Four patients and six controls were H63D homozygous and one was C282Y homozygous. There was a progressive increase in mean serum iron ([Fe]) and transferrin saturations from patients with no mutation ([Fe] = 16.3 mu mol/l, transferrin saturation = 23.7%) through H63D heterozygotes (17.5 mu mol/l, 25.8%), C282Y heterozygotes (17.1 mu mol/l, 26.6%), H63D homozygotes (20.0 mu mol/l, 33.5%), compound heterozygotes (26.8 mu mol/l, 41.7%), and C282Y homozygotes (34 mu mol/l, 71%). At follow up (median 90 months) the rate of death or cardiac transplantation was 52/207 (25%). C282Y heterozygotes had less ventricular dilatation (mean (SD): 59.9 (1.7) mm v 64.9 (0.9) mm, p < 0.05), better fractional shortening (24 (1.7)% v 18.8 (1.4)%, p < 0.01), and a trend towards improved survival without transplantation. [Fe] and transferrin saturation did not correlate with disease severity and were not associated with reduced survival. Conclusions-The frequency of the H63D mutation is significantly increased in patients with idiopathic dilated cardiomyopathy. As H63D has a relatively minor effect on iron status, the mechanism of this association may be unrelated to iron metabolism.
引用
收藏
页码:541 / 547
页数:7
相关论文
共 50 条
  • [11] Mutations in the Z-band protein myopalladin gene and idiopathic dilated cardiomyopathy
    Duboscq-Bidot, Laetitia
    Xu, Peng
    Charron, Philippe
    Neyroud, Nathalie
    Dilanian, Gilles
    Millaire, Alain
    Bors, Valeria
    Komajda, Michel
    Villard, Eric
    CARDIOVASCULAR RESEARCH, 2008, 77 (01) : 118 - 125
  • [12] Mutations in the Z band protein Myopalladin gene are responsible for idiopathic dilated cardiomyopathy
    Villard, E.
    Charron, P.
    Duboscq-Bidot, L.
    Xu, P.
    Dilanian, G.
    Millaire, A.
    Bors, V.
    Komajda, M.
    EUROPEAN HEART JOURNAL, 2007, 28 : 257 - 257
  • [13] Lamine gene mutations in dilated cardiomyopathy
    Zaklyazminskaya, EV
    Chuhrova, AL
    Tverskay, SM
    Rudenskay, GE
    Treshkur, TV
    Gudkova, AY
    Parmon, EV
    Kotlukova, NP
    Chapurnyh, AV
    Serebrennikova, TE
    Polyakov, AV
    KARDIOLOGIYA, 2005, 45 (02) : 47 - 52
  • [14] Prevalence of haemochromatosis gene mutations in idiopathic atrial arrhythmias
    Bhachu, RS
    Davis, A
    Paisey, J
    Gomez, M
    Yue, A
    Roberts, PR
    Morgan, JM
    Rosenberg, WM
    EUROPEAN HEART JOURNAL, 2003, 24 : 284 - 284
  • [15] Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy
    Hayashi, T
    Arimura, T
    Itoh-Satoh, M
    Ueda, K
    Hohda, S
    Inagaki, N
    Takahashi, M
    Hori, H
    Yasunami, M
    Nishi, H
    Koga, Y
    Nakamura, H
    Matsuzaki, M
    Choi, BY
    Bae, SW
    You, CW
    Han, KH
    Park, JE
    Knöll, R
    Hoshijima, M
    Chien, KR
    Kimura, A
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (11) : 2192 - 2201
  • [16] Mitochondrial DNA point mutations in idiopathic dilated cardiomyopathy
    Khogali, SS
    Mayosi, BM
    Beattie, JM
    Watkins, HC
    Poulton, J
    CIRCULATION, 1998, 98 (17) : 245 - 245
  • [17] KIR and cytokine gene polymorphisms in idiopathic dilated cardiomyopathy
    Pavlova, Yelena A.
    Kolesar, Libor
    Striz, Ilja
    Malek, Ivan
    Slavcev, Antonij
    TISSUE ANTIGENS, 2009, 73 (05): : 488 - 489
  • [18] Idiopathic dilated cardiomyopathy
    Cabrera, JRC
    MEDICAL HYPOTHESES, 1999, 53 (03) : 260 - 262
  • [19] IDIOPATHIC DILATED CARDIOMYOPATHY
    HACKEL, AJ
    WAGNER, G
    HACKEL, DB
    CLINICAL CARDIOLOGY, 1994, 17 (05) : 270 - 272
  • [20] IDIOPATHIC DILATED CARDIOMYOPATHY
    POOLEWILSON, PA
    BRITISH MEDICAL JOURNAL, 1990, 300 (6735): : 1340 - 1341